ISSN (Print):
1570-1611
ISSN (Online):
1875-6212
Download PDF Flyer

Current Vascular Pharmacology

Special Promotion
To Our Authors
Publication charges waived for original research articles until April 30th, 2024. No charges for reviews, editorials, and letters

Impact Factor: 4.5

Indexed in: Scopus, SCI Expanded, MEDLINE/PubMed... View all

Volume 22 , Issues 6, 2024

Back Journal Home

Institutional Members
Impact Factor
Web of Science Impact Factor

Current: 4.5
5 - Year: 3.8

Ranking & Category

  • 42nd of 65 in Peripheral Vascular Disease
  • 164th of 261 in Pharmacology & Pharmacy

Topic(s) Covered

3 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Current Vascular Pharmacology publishes clinical and research-based reviews/mini-reviews, original research articles, letters, debates, drug clinical trial studies and guest edited issues to update all those concerned with the treatment of vascular disease, bridging the gap between clinical practice and ongoing research.

Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units).

Endorsement(s)
"Essential reading for cardiovascular scientists and physicians, pharmaceutical organizations and medical universities."

Greg Dusting
Univ. of Melbourne, Australia
COPE Compliant
Archived in
© 2024 Bentham Science Publishers | Privacy Policy